448 related articles for article (PubMed ID: 12365017)
21. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
[TBL] [Abstract][Full Text] [Related]
22. Carboplatin induces apoptotic cell death through downregulation of constitutively active nuclear factor-kappaB in human HPV-18 E6-positive HEp-2 cells.
Singh S; Bhat MK
Biochem Biophys Res Commun; 2004 May; 318(2):346-53. PubMed ID: 15120608
[TBL] [Abstract][Full Text] [Related]
23. Decrease in RelA phosphorylation by inhibiting protein kinase A induces cell death in NF-kappaB-expressing and drug-resistant tumor cells.
Manna SK; Gangadharan C
Mol Immunol; 2009 Apr; 46(7):1340-50. PubMed ID: 19128834
[TBL] [Abstract][Full Text] [Related]
24. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
Hermisson M; Weller M
Cell Death Differ; 2003 Sep; 10(9):1078-89. PubMed ID: 12934082
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
Uwagawa T; Li Z; Chang Z; Xia Q; Peng B; Sclabas GM; Ishiyama S; Hung MC; Evans DB; Abbruzzese JL; Chiao PJ
Cancer; 2007 May; 109(10):2142-53. PubMed ID: 17410536
[TBL] [Abstract][Full Text] [Related]
26. Dominant signals leading to inhibitor kappaB protein degradation mediate CD40 ligand rescue of WEHI 231 immature B cells from receptor-mediated apoptosis.
Schauer SL; Bellas RE; Sonenshein GE
J Immunol; 1998 May; 160(9):4398-405. PubMed ID: 9574544
[TBL] [Abstract][Full Text] [Related]
27. Parthenolide cooperates with NS398 to inhibit growth of human hepatocellular carcinoma cells through effects on apoptosis and G0-G1 cell cycle arrest.
Ralstin MC; Gage EA; Yip-Schneider MT; Klein PJ; Wiebke EA; Schmidt CM
Mol Cancer Res; 2006 Jun; 4(6):387-99. PubMed ID: 16778086
[TBL] [Abstract][Full Text] [Related]
28. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak MA; Bellas RE; Kim DW; Zanieski GJ; Rogers AE; Traish AM; Sonenshein GE
J Clin Invest; 1997 Dec; 100(12):2952-60. PubMed ID: 9399940
[TBL] [Abstract][Full Text] [Related]
29. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
Shehata M; Shehata M; Shehata F; Pater A
Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959
[TBL] [Abstract][Full Text] [Related]
30. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
31. Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera.
Lee JH; Jung HS; Giang PM; Jin X; Lee S; Son PT; Lee D; Hong YS; Lee K; Lee JJ
J Pharmacol Exp Ther; 2006 Jan; 316(1):271-8. PubMed ID: 16183703
[TBL] [Abstract][Full Text] [Related]
32. The involvement of nuclear factor-kappa B in cyclooxygenase-2 overexpression in murine colon cancer cells transduced with herpes simplex virus thymidine kinase gene.
Konson A; Mahajna JA; Danon A; Rimon G; Agbaria R
Cancer Gene Ther; 2006 Dec; 13(12):1093-104. PubMed ID: 16841079
[TBL] [Abstract][Full Text] [Related]
33. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation.
Rödel F; Hantschel M; Hildebrandt G; Schultze-Mosgau S; Rödel C; Herrmann M; Sauer R; Voll RE
Int J Radiat Biol; 2004 Feb; 80(2):115-23. PubMed ID: 15164793
[TBL] [Abstract][Full Text] [Related]
34. Activation of NF-kappaB by Toxoplasma gondii correlates with increased expression of antiapoptotic genes and localization of phosphorylated IkappaB to the parasitophorous vacuole membrane.
Molestina RE; Payne TM; Coppens I; Sinai AP
J Cell Sci; 2003 Nov; 116(Pt 21):4359-71. PubMed ID: 12966164
[TBL] [Abstract][Full Text] [Related]
35. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue.
Sasaki N; Morisaki T; Hashizume K; Yao T; Tsuneyoshi M; Noshiro H; Nakamura K; Yamanaka T; Uchiyama A; Tanaka M; Katano M
Clin Cancer Res; 2001 Dec; 7(12):4136-42. PubMed ID: 11751513
[TBL] [Abstract][Full Text] [Related]
36. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells.
Kim DW; Gazourian L; Quadri SA; Romieu-Mourez R; Sherr DH; Sonenshein GE
Oncogene; 2000 Nov; 19(48):5498-506. PubMed ID: 11114727
[TBL] [Abstract][Full Text] [Related]
37. Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway.
Epinat JC; Gilmore TD
Oncogene; 1999 Nov; 18(49):6896-909. PubMed ID: 10602465
[TBL] [Abstract][Full Text] [Related]
38. Effects of carcinogen-induced transcription factors on the activation of hepatitis B virus expression in human hepatoblastoma HepG2 cells and its implication on hepatocellular carcinomas.
Banerjee R; Caruccio L; Zhang YJ; McKercher S; Santella RM
Hepatology; 2000 Aug; 32(2):367-74. PubMed ID: 10915744
[TBL] [Abstract][Full Text] [Related]
39. A role for MHBst167/HBx in hepatitis B virus-induced renal tubular cell apoptosis.
Hong L; Zhang J; Min J; Lu J; Li F; Li H; Guo S; Li Q
Nephrol Dial Transplant; 2010 Jul; 25(7):2125-33. PubMed ID: 20118485
[TBL] [Abstract][Full Text] [Related]
40. Signal-specific and phosphorylation-dependent RelB degradation: a potential mechanism of NF-kappaB control.
Marienfeld R; Berberich-Siebelt F; Berberich I; Denk A; Serfling E; Neumann M
Oncogene; 2001 Dec; 20(56):8142-7. PubMed ID: 11781828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
